Vivodyne has raised $40 million in new Series A financing to scale its robotics+AI approach to testing on thousands...
Read more
The future of drug development is changing, and Vivodyne is helping lead the way. With the FDA’s new push...
Read more
From childhood aspirations of being a doctor to a pivotal role in lab operations, Lois Tolvinski’s journey highlights the...
Read more
Vivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development,...
Read more
Biotech startup Vivodyne is planning to revolutionize drug development with an AI-powered robot that can grow, dose, and analyze...
Read more
Vivodyne announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos...
Read more
Vivodyne announced today that it has expanded its executive team with Dr. Susan Billings joining as its Chief Commercial...
Read more
Center for Contemporary Sciences (CCS) Applauds the Senate for Passing the FDA Modernization Act 2.0
The U.S. Senate unanimously passed the FDA Modernization Act 2.0, S.5002 on September 28. As we shared last month,...
Read more
Dr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...
Read more
Vivodyne has been named #1 in the list of Fast Company’s World’s Most Innovative “Small but Mighty” Companies for 2022. This...
Read more